Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication
Author:
Funder
Harvard Medical School
Publisher
Elsevier BV
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference85 articles.
1. Diabetes 2030: Insights from yesterday, today, and future trends;Rowley;Popul Health Manag,2017
2. 4. Comprehensive medical evaluation and assessment of comorbidities: Standards of medical care in diabetes—2020;Diabetes Care,2020
3. Diabetes and cancer: A consensus report;Giovannucci;CA Cancer J Clin,2010
4. Type 1 diabetes mellitus and risk of cancer: A meta-analysis of observational studies;Sona;Jpn J Clin Oncol,2018
5. Type 2 diabetes and cancer: Umbrella review of meta-analyses of observational studies;Tsilidis;BMJ,2015
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo;Scientific Reports;2024-06-14
2. Spatial analysis of cholangiocarcinoma in relation to diabetes mellitus and Opisthorchis viverrini infection in Northeast Thailand;Scientific Reports;2024-05-07
3. Preoperative profiles of plasma amino acids and derivatives distinguish periampullary cancer and benign disease;BMC Cancer;2024-05-03
4. γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus;World Journal of Gastroenterology;2023-07-28
5. Type 2 Diabetes Mellitus and Liver Disease: Across the Gut–Liver Axis from Fibrosis to Cancer;Nutrients;2023-05-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3